Sign in to edit your profile (add interests, mentoring, photo, etc.)
    Keywords
    Last Name
    Institution

    Monica Gandhi, MD, MPH

    TitleAssociate Professor of Clinical
    SchoolUCSF School of Medicine
    DepartmentMedicine
    Address1001 Potrero Ave, SFGH 80
    San Francisco CA 94143
    Phone415-502-6285

       Biography 
       Awards and Honors
      San Francisco General Hospital2012Meg Newman Teaching Award from the Positive Health Practice
      2011Sarlo Award for Teaching Excellence, AIDS Research Institute

       Overview 
       Overview
      Monica Gandhi MD, MPH is an Associate Professor of Medicine in the Divisions of HIV/AIDS and Infectious Diseases. Dr. Gandhi completed her M.D. at Harvard Medical School and then came to UCSF in 1996 for residency training in Internal Medicine. After her residency, Dr. Gandhi completed a fellowship in Infectious Diseases and a postdoctoral fellowship at the Center for AIDS Prevention Studies, both at UCSF. She also obtained a Masters in Public Health from Berkeley in 2001 with a focus on Epidemiology and Biostatistics.

      Dr. Gandhi’s clinical and research career has been focused exclusively in HIV-infected women. Besides directing the AIDS Consult Service at San Francisco General Hospital and attending on the Infectious Diseases consult service, she serves as an HIV and primary care provider in the Women’s HIV Clinic at the Positive Health Practice, a multidisciplinary specialty clinic for HIV-infected women in San Francisco. Her research efforts have focused on HIV/AIDS in U.S. women through the Women's Interagency HIV Study (WIHS), a large multisite, prospective cohort study established in 1994 to study the natural history, clinical and laboratory findings of HIV in women. Her particular research is on differences between men and women in terms of antiretroviral exposure and finding low-cost solutions to measuring antiretroviral levels in resource-poor settings, such as determining drug levels in hair samples. Dr. Gandhi has also participated in research efforts involving the impact of HIV/AIDS in women in India.

      Dr. Gandhi also has an interest at UCSF in HIV education and mentorship. Dr. Gandhi co-directs the public health section of the Immunity, Inflammation and Infection (I-3) course for the UCSF medical students, co-directs the “Communicable Diseases of Global Health Importance” course in the Global Health Sciences Masters program, and serves as the Education Director of the HIV/AIDS Division. She also serves as the program director of the UCSF Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) K12 scholarship which funds and nurtures early career scientists in women's health research. She also serves as the principal investigator of an R24 mentoring grant from the NIH focused on nurturing early career investigators of diversity in HIV research.


       Bibliographic 
       Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Baxi S and Gandhi M. Infectious Diseases in Clinical Practice. An Incidental Abscess in a Patient with Acquired Immunodeficiency Syndrome. 2012; (in press).
      2. Gandhi M, Greenblatt RM, Bacchetti P, Jin C, Huang Y, Anastos K, Cohen M, DeHovitz JA, Sharp GB, Gange SJ, Liu C, Hanson SC, Aouizerat B. Journal of Infectious Diseases. A Single Nucleotide Polymorphism in CYP2B6 Leads to >3-fold Increases in Efavirenz Concentrations in Intensive PK Curves and Hair Samples in HIV-infected Women. 2012; 9(206):1453-1461.
      3. Geng EH, Hare BH, Kahn JO, Jain V, Nunnery TV, Christopoulos K, Deeks SG, Gandhi M, Havlir DV. Clinical Infectious Diseases. The Effect of a “Universal Antiretroviral Therapy” Recommendation on HIV RNA Levels among HIV-Infected Patients Entering Care with a CD4 Count Greater than 500/µl in a Public Health Setting. 2012; (in press).
      4. Geng EH, Hare CB, Kahn JO, Jain V, Van Nunnery T, Christopoulos KA, Deeks SG, Gandhi M, Havlir DV. The Effect of a "Universal Antiretroviral Therapy" Recommendation on HIV RNA Levels Among HIV-Infected Patients Entering Care With a CD4 Count Greater Than 500/µL in a Public Health Setting. Clin Infect Dis. 2012 Dec; 55(12):1690-7.
        View in: PubMed
      5. Gandhi M, Greenblatt RM, Bacchetti P, Jin C, Huang Y, Anastos K, Cohen M, Dehovitz JA, Sharp GB, Gange SJ, Liu C, Hanson SC, Aouizerat B. A single-nucleotide polymorphism in CYP2B6 leads to >3-fold increases in efavirenz concentrations in plasma and hair among HIV-infected women. J Infect Dis. 2012 Nov; 206(9):1453-61.
        View in: PubMed
      6. Merenstein D, Wang C, Gandhi M, Robison E, Levine AM, Schwartz RM, Weber KM, Liu C. An investigation of the possible interaction between the use of Vitamin C and highly active antiretroviral therapy (HAART) adherence and effectiveness in treated HIV+ women. Complement Ther Med. 2012 Aug; 20(4):222-7.
        View in: PubMed
      7. Liu C, Wang C, Robison E, Levine AM, Gandhi M, Schwartz R, Weber KM, Merenstein D. Short-term garlic supplementation and highly active antiretroviral treatment adherence, CD4+ cell counts, and human immunodeficiency virus viral load. Altern Ther Health Med. 2012 Jan-Feb; 18(1):18-22.
        View in: PubMed
      8. Geng EH, Kahn JS, Chang OC, Hare CB, Christopoulos KA, Jones D, Petersen ML, Deeks SG, Havlir DV, Gandhi M. The effect of AIDS Clinical Trials Group Protocol 5164 on the time from Pneumocystis jirovecii pneumonia diagnosis to antiretroviral initiation in routine clinical practice: a case study of diffusion, dissemination, and implementation. Clin Infect Dis. 2011 Nov; 53(10):1008-14.
        View in: PubMed
      9. Huang Y, Yang Q, Yoon K, Lei Y, Shi R, Gee W, Lin ET, Greenblatt RM, Gandhi M. Microanalysis of the antiretroviral nevirapine in human hair from HIV-infected patients by liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem. 2011 Oct; 401(6):1923-33.
        View in: PubMed
      10. Ikediobi O, Aouizerat B, Xiao Y, Gandhi M, Gebhardt S, Warnich L. Analysis of pharmacogenetic traits in two distinct South African populations. Hum Genomics. 2011 May; 5(4):265-82.
        View in: PubMed
      11. Chandy S, Singh G, Heylen E, Gandhi M, Ekstrand ML. Treatment switching in South Indian patients on HAART: what are the predictors and consequences? AIDS Care. 2011 May; 23(5):569-77.
        View in: PubMed
      12. Gandhi M, Ameli N, Bacchetti P, Anastos K, Gange SJ, Minkoff H, Young M, Milam J, Cohen MH, Sharp GB, Huang Y, Greenblatt RM. Atazanavir concentration in hair is the strongest predictor of outcomes on antiretroviral therapy. Clin Infect Dis. 2011 May; 52(10):1267-75.
        View in: PubMed
      13. van Zyl GU, van Mens TE, McIlleron H, Zeier M, Nachega JB, Decloedt E, Malavazzi C, Smith P, Huang Y, van der Merwe L, Gandhi M, Maartens G. Low lopinavir plasma or hair concentrations explain second-line protease inhibitor failures in a resource-limited setting. J Acquir Immune Defic Syndr. 2011 Apr; 56(4):333-9.
        View in: PubMed
      14. Liu C, Yang Y, Gange SJ, Weber K, Sharp GB, Wilson TE, Levine A, Robison E, Goparaju L, Gandhi M, Ganhdi M, Merenstein D. Disclosure of complementary and alternative medicine use to health care providers among HIV-infected women. AIDS Patient Care STDS. 2009 Nov; 23(11):965-71.
        View in: PubMed
      15. Iobst S, Gandhi M. The feminization of an epidemic. Women and HIV in the United States. Posit Aware. 2009 Jul-Aug; 20(4):34-9.
        View in: PubMed
      16. Gandhi M, Benet LZ, Bacchetti P, Kalinowski A, Anastos K, Wolfe AR, Young M, Cohen M, Minkoff H, Gange SJ, Greenblatt RM. Nonnucleoside reverse transcriptase inhibitor pharmacokinetics in a large unselected cohort of HIV-infected women. J Acquir Immune Defic Syndr. 2009 Apr 15; 50(5):482-91.
        View in: PubMed
      17. Merenstein D, Schneider MF, Cox C, Schwartz R, Weber K, Robison E, Gandhi M, Richardson J, Plankey MW. Association of child care burden and household composition with adherence to highly active antiretroviral therapy in the Women's Interagency HIV Study. AIDS Patient Care STDS. 2009 Apr; 23(4):289-96.
        View in: PubMed
      18. Gandhi M, Ameli N, Bacchetti P, Gange SJ, Anastos K, Levine A, Hyman CL, Cohen M, Young M, Huang Y, Greenblatt RM. Protease inhibitor levels in hair strongly predict virologic response to treatment. AIDS. 2009 Feb 20; 23(4):471-8.
        View in: PubMed
      19. Huang Y, Gandhi M, Greenblatt RM, Gee W, Lin ET, Messenkoff N. Sensitive analysis of anti-HIV drugs, efavirenz, lopinavir and ritonavir, in human hair by liquid chromatography coupled with tandem mass spectrometry. Rapid Commun Mass Spectrom. 2008 Nov; 22(21):3401-9.
        View in: PubMed
      20. Merenstein D, Yang Y, Schneider MF, Goparaju L, Weber K, Sharma A, Levine AM, Sharp GB, Gandhi M, Liu C. Association of complementary and alternative medicine use with highly active antiretroviral therapy initiation. Altern Ther Health Med. 2008 Sep-Oct; 14(5):18-22.
        View in: PubMed
      21. Szczech LA, Golub ET, Springer G, Augenbraun M, Young M, Gandhi M, Gillepsie BS, Anastos K. Highly active antiretroviral therapy reduces urinary albumin excretion in women with HIV infection. J Acquir Immune Defic Syndr. 2008 Jul 1; 48(3):360-1.
        View in: PubMed
      22. Merenstein DJ, Schneider MF, Cox C, Schwartz R, Weber K, Robison E, Gandhi M, Richardson J, Plankey MW. Association between living with children and adherence to highly active antiretroviral therapy in the Women's Interagency HIV Study. Pediatrics. 2008 Apr; 121(4):e787-93.
        View in: PubMed
      23. Golub ET, Benning L, Sharma A, Gandhi M, Cohen MH, Young M, Gange SJ. Patterns, predictors, and consequences of initial regimen type among HIV-infected women receiving highly active antiretroviral therapy. Clin Infect Dis. 2008 Jan 15; 46(2):305-12.
        View in: PubMed
      24. Liu C, Lerch V, Weber K, Schneider MF, Sharp GB, Gorapaju L, Sharma A, Levine A, Gandhi M, Merenstein D. Association between complementary and alternative medicine use and adherence to highly active antiretroviral therapy in the Women's Interagency HIV Study. J Altern Complement Med. 2007 Dec; 13(10):1053-6.
        View in: PubMed
      25. Riley ED, Gandhi M, Hare C, Cohen J, Hwang S. Poverty, unstable housing, and HIV infection among women living in the United States. Curr HIV/AIDS Rep. 2007 Dec; 4(4):181-6.
        View in: PubMed
      26. Wilson TE, Feldman J, Vega MY, Gandhi M, Richardson J, Cohen MH, McKaig R, Ostrow D, Robison E, Gange SJ. Acquisition of new sexual partners among women with HIV infection: patterns of disclosure and sexual behavior within new partnerships. AIDS Educ Prev. 2007 Apr; 19(2):151-9.
        View in: PubMed
      27. Feldman JG, Minkoff H, Schneider MF, Gange SJ, Cohen M, Watts DH, Gandhi M, Mocharnuk RS, Anastos K. Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women's interagency HIV study. Am J Public Health. 2006 Jun; 96(6):1060-5.
        View in: PubMed
      28. Gandhi M, Ameli N, Bacchetti P, Sharp GB, French AL, Young M, Gange SJ, Anastos K, Holman S, Levine A, Greenblatt RM. Eligibility criteria for HIV clinical trials and generalizability of results: the gap between published reports and study protocols. AIDS. 2005 Nov 4; 19(16):1885-96.
        View in: PubMed
      29. Silverberg MJ, Gore ME, French AL, Gandhi M, Glesby MJ, Kovacs A, Wilson TE, Young MA, Gange SJ. Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the Women's Interagency HIV Study. Clin Infect Dis. 2004 Sep 1; 39(5):717-24.
        View in: PubMed
      30. Gandhi M, Koelle D, Ameli N, Bacchetti P, Greenspan J, Navazesh M, Anastos K, Greenblatt RM . Journal of Dental Research. Salivary shedding of human herpesvirus-8 among HIV-infected women is more frequent at higher CD4 cell counts. 2004; 3(83):639-643.
      31. Gandhi M, Aweeka F, Greenblatt RM, Blaschke TF. Sex differences in pharmacokinetics and pharmacodynamics. Annu Rev Pharmacol Toxicol. 2004; 44:499-523.
        View in: PubMed
      32. Gandhi M, Greenblatt RM. Human herpesvirus 8, Kaposi's sarcoma, and associated conditions. Clin Lab Med. 2002 Dec; 22(4):883-910.
        View in: PubMed
      33. Gandhi M, Greenblatt RM. Hair it is: the long and short of monitoring antiretroviral treatment. Ann Intern Med. 2002 Oct 15; 137(8):696-7.
        View in: PubMed
      34. Gandhi M, Bacchetti P, Miotti P, Quinn TC, Veronese F, Greenblatt RM. Does patient sex affect human immunodeficiency virus levels? Clin Infect Dis. 2002 Aug 1; 35(3):313-22.
        View in: PubMed
      Monica's Networks
      Click the "See All" links for more information and interactive visualizations!
      Related Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Related Authors
      People who share similar concepts with this person.
      _
      Same Department
      Back to TOP